Journal of Microbiology and Biotechnology

The Korean Society for Microbiology and Biotechnology (한국미생물·생명공학회)
권호 표지
DOI QR코드

DOI QR Code

Elucidation of the Inhibitory Mechanisms of Nipponoparmelia laevior Lichen Extract against Influenza A (H1N1) Virus through Proteomic Analyses

  • Cuong, Tran Van (Department of Food Science and Technology and Foodborne Virus Research Center, Chonnam National University) ;
  • Cho, Se-Young (Biological Disaster Analysis Group, Korea Basic Science Institute) ;
  • Kwon, Joseph (Biological Disaster Analysis Group, Korea Basic Science Institute) ;
  • Kim, Duwoon (Department of Food Science and Technology and Foodborne Virus Research Center, Chonnam National University)
  • Received : 2019.05.21
  • Accepted : 2019.06.25
  • Published : 2019.07.28
Download PDF
⟨ Previous Next ⟩

Abstract

Lichens contain diverse bioactive secondary metabolites with various chemical and biological properties, which have been widely studied. However, details of the inhibitory mechanisms of their secondary metabolites against influenza A virus (IAV) have not been documented. Here, we investigated the antiviral effect of lichen extracts, obtained from South Korea, against IAV in MDCK cells. Of the lichens tested, Nipponoparmelia laevior (LC24) exhibited the most potent inhibitory effect against IAV infection. LC24 extract significantly increased cell viability, and reduced apoptosis in IAV-infected cells. The LC24 extract also markedly reduced (~ 3.2 log-fold) IAV mRNA expression after 48 h of infection. To understand the antiviral mechanism of LC24 against IAV, proteomic (UPLC-$HDMS^E$) analysis was performed to compare proteome modulation in IAV-infected (V) vs. mock (M) and LC24+IAV (LCV) vs. V cells. Based on Ingenuity Pathway Analysis (IPA), LC24 inhibited IAV infection by modulating several antiviral-related genes and proteins (HSPA4, HSPA5, HSPA8, ANXA1, ANXA2, $HIF-1{\alpha}$, AKT1, MX1, HNRNPH1, HNRNPDL, PDIA3, and VCP) via different signaling pathways, including $HIF-1{\alpha}$ signaling, unfolded protein response, and interferon signaling. These molecules were identified as the specific biomarkers for controlling IAV in vitro and further confirmation of their potential against IAV in vivo is required. Our findings provide a platform for further studies on the application of lichen extracts against IAV.

Keywords

References

  1. Long JS, Mistry B, Haslam SM, Barclay WS. 2019. Host and viral determinants of influenza A virus species specificity. Nat. Rev. Microbiol. 17: 67-81. https://doi.org/10.1038/s41579-018-0115-z
  2. Dou D, Revol R, Ostbye H, Wang H, Daniels R. 2018. Influenza A virus cell entry, replication, virion assembly and movement. Front Immunol. 9: 1581. https://doi.org/10.3389/fimmu.2018.01581
  3. Medina RA. 2018. 1918 Influenza Virus: 100 years on, are we prepared against the next influenza pandemic? Nat. Rev. Microbiol. 16: 61-62. https://doi.org/10.1038/nrmicro.2017.174
  4. WHO. 2019. Influenza (seasonal). Influenza. URL: https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal) Accessed on May 10th 2019.
  5. Ju H, Zhang J, Huang B, Kang D, Huang B, Liu X, et al. 2017. Inhibitors of influenza virus polymerase acidic (PA) endonuclease: contemporary developments and perspectives. J. Med. Chem. 60: 3533-3551. https://doi.org/10.1021/acs.jmedchem.6b01227
  6. van de Wakker SI, Fischer MJE, Oosting RS. 2017. New drug-strategies to tackle viral-host interactions for the treatment of influenza virus infections. Eur. J. Pharmacol. 809: 178-190. https://doi.org/10.1016/j.ejphar.2017.05.038
  7. Regoes RR, Bonhoeffer S. 2006. Emergence of drug-resistant influenza virus: population dynamical considerations. Science 312: 389-391. https://doi.org/10.1126/science.1122947
  8. Kaasalainen U, Fewer DP, Jokela J, Wahlsten M, Sivonen K, Rikkinen J. 2012. Cyanobacteria produce a high variety of hepatotoxic peptides in lichen symbiosis. Proc. Natl. Acad. Sci. USA 109: 5886-5891. https://doi.org/10.1073/pnas.1200279109
  9. Shukla V, Joshi GP, Rawat MSM. 2010. Lichens as a potential natural source of bioactive compounds: a review. Phytochem. Rev. 9: 303-314. https://doi.org/10.1007/s11101-010-9189-6
  10. Feuerer T, Hawksworth DL. 2007. Biodiversity of lichens, including a world-wide analysis of checklist data based on Takhtajan's floristic regions. Biodivers. Conserv. 16: 85-98. https://doi.org/10.1007/s10531-006-9142-6
  11. Ahmadjian V. 1995. Lichens are more important than you think. Bioscience 45: 124. https://doi.org/10.1093/bioscience/45.3.124
  12. Stocker-Wörgötter E. 2008. Metabolic diversity of lichen-forming ascomycetous fungi: culturing, polyketide and shikimatemetabolite production, and PKS genes. Nat. Prod. Rep. 25: 188-200. https://doi.org/10.1039/B606983P
  13. Zhou R, Yang Y, Park S, Nguyen TT, Seo Y, Lee KH, et al. 2017. The lichen secondary metabolite atranorin suppresses lung cancer cell motility and tumorigenesis. Sci. Rep. 7: 8136. https://doi.org/10.1038/s41598-017-08225-1
  14. Nguyen TT, Yoon S, Yang Y, Lee H-B, Oh S, Jeong M-H, et al. 2014. Lichen secondary metabolites in Flavocetraria cucullata exhibit anti-cancer effects on human cancer cells through the induction of apoptosis and suppression of tumorigenic potentials. PLoS One 9: e111575. https://doi.org/10.1371/journal.pone.0111575
  15. Yilmaz M, Türk AÖ, Kivanç M, Tay T. 2004. The antimicrobial activity of extracts of the lichen Cladonia foliacea and its (-)-usnic acid, atranorin, and fumarprotocetraric acid constituents. Z. Naturforsch C. 59(3-4): 249-254. https://doi.org/10.1515/znc-2004-3-423
  16. Honda NK, Freitas DS, Micheletti AC, Pereira Carvalho NC, Spielmann AA, Da Silva Canez L. 2016. Parmotrema screminiae (Parmeliaceae), a novel lichen species from Brazil with potent antimicrobial activity. Orbital - Electron J. Chem. 8: 334-340.
  17. Kosanic M, Rankovic B, Vukojevic J. 2011. Antioxidant properties of some lichen species. J. Food Sci. Technol. 48: 584-590. https://doi.org/10.1007/s13197-010-0174-2
  18. Brisdelli F, Perilli M, Sellitri D, Piovano M, Garbarino JA, Nicoletti M, et al. 2013. Cytotoxic activity and antioxidant capacity of purified lichen metabolites: an in vitro study. Phyther. Res. 27: 431-437. https://doi.org/10.1002/ptr.4739
  19. Perry NB, Benn MH, Brennan NJ, Burgess EJ, Ellis G, Galloway DJ, et al. 1999. Antimicrobial, antiviral and cytotoxic activity of New Zealand lichens. Lichenologist 31: 627-636. https://doi.org/10.1006/lich.1999.0241
  20. Daowan Lai, Damian C. Odimegwu, Charles Esimone, Thomas Grunwald PP. 2013. Phenolic compounds with in vitro activity against respiratory syncytial virus from the Nigerian lichen Ramalina farinacea. Planta Med. 79: 1440-1446. https://doi.org/10.1055/s-0033-1350711
  21. Esimone CO, Ofokansi KC, Adikwu MU, Ibezim EC, Abonyi DO, Odaibo GN, et al. 2007. In vitro evaluation of the antiviral activity of extracts from the lichen Parmelia perlata (L.) Ach. against three RNA viruses. J. Infect. Dev. Ctries. 1: 315-320. https://doi.org/10.3855/jidc.370
  22. Vu TH, Lamer AC Le, Lalli C, Samson JBM, Devehat FL Le, Seyec J Le. 2015. Depsides: Lichen metabolites active against hepatitis C virus. PLoS One 10(3): e120405.
  23. Tanas S, Odabasoglu F, Halici Z, Cakir A, Aygun H, Ali A, et al. 2010. Evaluation of anti-inflammatory and antioxidant activities of Peltigera rufescens lichen species in acute and chronic inflammation models. J. Nat. Med. 64: 42-49. https://doi.org/10.1007/s11418-009-0367-z
  24. Studzinska-Sroka E, Dubino A. 2018. Lichens as a source of chemical compounds with anti-inflammatory activity. Herba Polanica 64: 56-64. https://doi.org/10.2478/hepo-2018-0005
  25. Sokolov DN, Zarubaev V V, Shtro AA, Polovinka MP, Luzina OA, Komarova NI, et al. 2012. Anti-viral activity of (-)- and (+)-usnic acids and their derivatives against influenza virus A(H1N1)2009. Bioorg. Med. Chem. Lett. 22: 7060-7064. https://doi.org/10.1016/j.bmcl.2012.09.084
  26. Shtro AA, Zarubaev V V, Luzina OA, Sokolov DN, Kiselev OI, Salakhutdinov NF. 2014. Novel derivatives of usnic acid effectively inhibiting reproduction of influenza A virus. Bioorg. Med. Chem. 22: 6826-6836. https://doi.org/10.1016/j.bmc.2014.10.033
  27. Shtro A, Zarubaev V, Luzina O, Sokolov D, Salakhutdinov N. 2015. Derivatives of usnic acid inhibit broad range of influenza viruses and protect mice from lethal influenza infection. Antivir. Chem. Chemother. 24: 92-98. https://doi.org/10.1177/2040206616636992
  28. Vaidya B, Cho S-Y, Oh K-S, Kim SH, Kim YO, Jeong E-H, et al. 2016. Effectiveness of periodic treatment of quercetin against influenza A virus H1N1 through modulation of protein expression. J. Agric. Food Chem. 64: 4416-4425. https://doi.org/10.1021/acs.jafc.6b00148
  29. Lu X, Zhu H. 2005. Tube-Gel Digestion. Mol. Cell Proteomics 4: 1948-1958. https://doi.org/10.1074/mcp.M500138-MCP200
  30. Yang H-Y, Kwon J, Cho E-J, Choi H-I, Park C, Park H-R, et al. 2010. Proteomic analysis of protein expression affected by peroxiredoxin V knock-down in hypoxic kidney. J. Proteome Res. 9: 4003-4015. https://doi.org/10.1021/pr100190b
  31. Burniston JG, Connolly J, Kainulainen H, Britton SL, Koch LG. 2014. Label-free profiling of skeletal muscle using high-definition mass spectrometry. Proteomics 14: 2339-2344. https://doi.org/10.1002/pmic.201400118
  32. Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N, et al. 2003. TM4: A free, open-source system for microarray data management and analysis. Biotechniques 34: 374-378. https://doi.org/10.2144/03342mt01
  33. Muramoto Y, Noda T, Kawakami E, Akkina R, Kawaoka Y. 2013. Identification of novel influenza A virus proteins translated from PA mRNA. J. Virol. 87: 2455-2462. https://doi.org/10.1128/JVI.02656-12
  34. Fernandez-Moriano C, Divakar PK, Crespo A, Gomez-Serranillos MP. 2017. In vitro neuroprotective potential of lichen metabolite fumarprotocetraric acid via intracellular redox modulation. Toxicol. Appl. Pharmacol. 316: 83-94. https://doi.org/10.1016/j.taap.2016.12.020
  35. Fernandez-Moriano C, Divakar PK, Crespo A, Gomez-Serranillos MP. 2017. Protective effects of lichen metabolites evernic and usnic acids against redox impairment-mediated cytotoxicity in central nervous system-like cells. Food Chem. Toxicol. 105: 262-277. https://doi.org/10.1016/j.fct.2017.04.030
  36. Denisova O V, Soderholm S, Virtanen S, Von Schantz C, Bychkov D, Vashchinkina E, et al. 2014. Akt inhibitor MK2206 prevents influenza pH1N1 virus infection in vitro. Antimicrob. Agents Chemother. 58: 3689-3696. https://doi.org/10.1128/AAC.02798-13
  37. Guo X, Zhu Z, Zhang W, Meng X, Zhu Y, Han P, et al. 2017. Nuclear translocation of $HIF-1{\alpha}$ induced by influenza A (H1N1) infection is critical to the production of proinflammatory cytokines. Emerg. Microbes Infect. 6(5): e39. https://doi.org/10.1038/emi.2017.21
  38. Cha IS, Kwon J, Park S Bin, Jang H Bin, Nho SW, Kim YK, et al. 2013. Heat shock protein profiles on the protein and gene expression levels in olive flounder kidney infected with Streptococcus parauberis. Fish Shellfish Immunol. 34: 1455-1462. https://doi.org/10.1016/j.fsi.2013.03.355
  39. Kajihara M, Manzoor R, Fujikura D, Takada A, Yoshida R, Kuroda K, et al. 2014. Heat shock protein 70 modulates influenza A virus polymerase activity. J. Biol. Chem. 289: 7599-7614. https://doi.org/10.1074/jbc.M113.507798
  40. Batra J, Tripathi S, Kumar A, Katz JM, Cox NJ, Lal RB, et al. 2016. Human heat shock protein 40 (Hsp40/DnaJB1) promotes influenza A virus replication by assisting nuclear import of viral ribonucleoproteins. Sci. Rep. 6: 19063. https://doi.org/10.1038/srep19063
  41. Mirsaeidi M, Gidfar S, Vu A, Schraufnagel D. 2016. Annexins family: insights into their functions and potential role in pathogenesis of sarcoidosis. J. Transl. Med. 14: 89-97. https://doi.org/10.1186/s12967-016-0843-7
  42. Arora S, Lim W, Bist P, Perumalsamy R, Lukman HM, Li F, et al. 2016. Influenza A virus enhances its propagation through the modulation of Annexin-A1 dependent endosomal trafficking and apoptosis. Cell Death Differ. 23: 1243-1256. https://doi.org/10.1038/cdd.2016.19
  43. Ma Y, Sun J, Gu L, Bao H, Zhao Y, Shi L, et al. 2017. Annexin A2 (ANXA2) interacts with nonstructural protein 1 and promotes the replication of highly pathogenic H5N1 avian influenza virus. BMC Microbiol. 17: 191-199. https://doi.org/10.1186/s12866-017-1097-0
  44. LeBouder F, Lina B, Rimmelzwaan GF, Riteau B. 2010. Plasminogen promotes influenza A virus replication through an annexin 2-dependent pathway in the absence of neuraminidase. J. Gen. Virol. 91: 2753-2761. https://doi.org/10.1099/vir.0.023804-0
  45. Chang C-W, Peng T-Y, Yen H-R, Lin T-Y, Horng J-T, Wu M-S, et al. 2011. Mechanism of action of the suppression of influenza virus replication by Ko-Ken Tang through inhibition of the phosphatidylinositol 3-kinase/Akt signaling pathway and viral RNP nuclear export. J. Ethnopharmacol. 134: 614-623. https://doi.org/10.1016/j.jep.2011.01.005
  46. Werth N, Beerlage C, Rosenberger C, Yazdi AS, Edelmann M, Amr A, et al. 2010. Activation of hypoxia inducible factor 1 is a general phenomenon in infections with human pathogens. PLoS One 5: e11576. https://doi.org/10.1371/journal.pone.0011576
  47. Ren L, Zhang W, Han P, Zhang J, Zhu Y, Meng X, et al. 2019. Influenza A virus (H1N1) triggers a hypoxic response by stabilizing hypoxia-inducible $factor-1{\alpha}$ via inhibition of proteasome. Virology 530: 51-58. https://doi.org/10.1016/j.virol.2019.02.010
  48. Shrestha N, Bahnan W, Wiley DJ, Barber G, Fields KA, Schesser K. 2012. Eukaryotic initiation factor 2 (eIF2) signaling regulates proinflammatory cytokine expression and bacterial invasion. J. Biol. Chem. 287: 28738-28744. https://doi.org/10.1074/jbc.M112.375915
  49. Verhelst J, Parthoens E, Schepens B, Fiers W, Saelens X. 2012. Interferon-inducible protein MX1 inhibits influenza virus by interfering with functional viral ribonucleoprotein complex assembly. J. Virol. 86: 13445-13455. https://doi.org/10.1128/JVI.01682-12